What Do We Do With the Science of Monstrous Men?
By Daniel Engber,
Slate
| 07. 31. 2018
On May 18, W. French Anderson, known as the “father of gene therapy,” was released from prison on parole. Two weeks later, the 81-year-old scientist, pediatrician, and ex-con welcomed science writer Sharon Begley to his home in California for several days of interviews, which he gave with a GPS tracking device encircling his ankle. “This is what it has come to for a world-renowned scientist who was convicted of sexually molesting a colleague’s young daughter,” she writes at the top of her warm, weird, and at times outrageous profile for STAT last week.
There’s been a lot of talk, in recent months, about the legacies of monstrous men in the arts. We’ve reviewed the benefits and risks associated with their public shaming. We’ve re-appraised their prior work. We’ve wondered whether prodigious talents should be allowed to re-emerge and keep creating; and then we’ve theorized that our love of second chances enabled them from the start. Much less consideration has been given to the Monstrous Men in Science—the sundry research “pioneers” and “geniuses” who have turned out to be abusive bullies...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025
A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.
Bootstrap Bio...